Carsten Müller-Tidow

92PUBLICATIONS
523CO-AUTHORS
Gene and molecular therapyHaematologyHaematological tumoursMedical mycologyCellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (92)

|Jul 06, 2026
Author Correction: Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.

|Jul 01, 2026
Clinical decision support in hematological malignancies using a case-grounded AI agent.

|Jun 25, 2026
Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.

|Jun 12, 2026
High-risk single-refractory and double-refractory chronic lymphocytic leukemia: feasibility and impact of alloHCT.

|May 21, 2026
Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial.

|Apr 14, 2026
Inhibition of high CXCR4 with Motixafortide and absence of single-cell MRD predict outcome after AML consolidation.

Enise Ceran, Sonia Jaramillo, Anne Kathrin Merbach

Pageof 16

Frequent Collaborators

18 joint publications

Hartmut Goldschmidt

18 joint publications

Marc S Raab

17 joint publications

Christoph Röllig

15 joint publications

Martin Bornhäuser